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Abstract		
Background:	In	high-income	countries	the	prevalence	of	blindness	and	visual	
impairment	is	higher	among	women,	regardless	of	age	although	the	mechanisms	that	
produce	these	gender	inequalities	are	not	well	understood.	The	objectives	of	this	study	
were	to	analyse	gender	inequalities	in	the	prevalence	of	blindness	and	visual	
impairment,	age	of	onset,	diagnosed	and	undiagnosed	status,	and	related	eye	diseases	
among	visually	impaired	individuals.	
Methods:	Data	were	obtained	from	the	2008	Spanish	Survey	on	“Disability,	Personal	
Autonomy	and	Dependency	Situations,	(n=213,626)	participants	360	blind	(160	men	
and	200	women),	and	5,560	with	some	visual	impairment	(2,025	men	and	3,535	
women).	The	prevalence	of	blindness	and	visual	impairment,	age	of	onset	of	visual	
impairment,	and	diagnosed	and	undiagnosed	eye	diseases	was	calculated.	Hierarchical	
multiple	logistic	regression	models	were	fit	to	test	gender	differences.		
Results:	Women	were	more	likely	to	report	visual	impairment	[crude	OR=1.6	(95%	
CI:1.56-1.74)].	Prevalence	of	diagnosed	cataract	was	higher	among	visually	impaired	
women	[crude	OR=1.4	(95%	CI:	1.25-1.67)]	whereas	u diagnosed	eye	disease	[crude	
OR=0.7	(95%	CI:	0.64-0.81)]	or	diagnosed	glaucoma	[(aORsex=0.8	(95%	CI:	0.65-0.93)]	
were	more	frequent	among	visually	impairment	men.	These	associations	were	not	
explained	by	age	or	educational	level.	
Conclusions:	Strong	gender	inequalities	were	observed,	with	a	higher	prevalence	of	
visual	impairment	and	related	cataracts	among	women,	which	could	be	related	to	
gender	inequalities	in	access	to	health	care,	and	undiagnosed	eye	disease	and	related	
glaucoma	among	men,	which	could	be	related	to	their	gender	socialization	resulting	in	
less	frequent	and	effectively	use	of	health	care	services.			
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INTRODUCTION	
Blindness	and	low	vision	are	widely	recognized	as	a	global	public	health	problem	and	as	
important	causes	of	impairment.(1)	It	is	estimated	that	32.4	million	people	were	blind	
in	2010	(60%	women),	and	191	million	had	moderate	or	severe	visual	impairment	
(57%	women).(2)	The	cost	of	visual	impairment	is	estimated	at	about	$3	trillion	per	
year	worldwide,	and	this	burden	is	expected	to	increase	by	approximately	20%	within	
10	years.(3)	Globally,	visual	impairment	is	generally	more	prevalent	among	women,	
regardless	of	age,(4)	with	the	female/male	prevalence	ratio	estimated	to	be	1.1	to	1.5	in	
2010.(2)	The	prevalence	of	blindness	and	visual	impairment	is	also	higher	among	
women	in	high-income	countries,	regardless	of	age,(4,5)	although	the	mechanisms	that	
produce	these	gender	inequalities	are	not	well	understood.	Gender	inequalities	could	be	
the	result	of	gender	differences	in	incidence	or	in	the	causes	that	converts	incidence	in	
persistent	prevalence,	such	as	lower	health	care	access	or	the	chronification	of	the	
health	problem.	.	
Gender	inequalities	can	be	related	to	mechanisms	that	differ	by	sex,	including	access	
barriers	to	health	care	services	(6)	and	lower	treatment	effort	(7,8)	among	women,	or	
less	help-seeking	behaviour	resulting	in	delayed	diagnosis	and	treatment	among	men.	
Women	are	generally	more	likely	to	use	health	care	services,(8)	and	a	growing	body	of	
evidence	from	gender-specific	studies	highlights	the	tendency	among	men	to	delay	
seeking	help	when	they	become	ill.	Social	norms	regarding	traditional	masculinity	
constrain	help-seeking	among	men,	mainly	due	to	the	their	attributed	role	of	self-
sufficiency	and	restrained	emotional	expressivity,	influencing	their	perception	of	
symptoms	and	weakness.(9,10)	For	example,	an	Australian	study	found	that	women	
were	more	likely	to	use	optometrist	services,	a	fact	that	was	not	explained	by	incidence	
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or	barriers	to	access,	but	probably	by	differences	in	their	attitude	to	when	and	how	to	
seek	health	services.(11)		
Examining	gender	differences	in	visual	impairment	according	to	current	age,	age	of	
onset,	the	diagnosed	or	undiagnosed	reason	of	visual	impairment,	and	the	causes	of	
blindness	and	visual	impairment	among	people	with	a	diagnosis	could	contribute	to	the	
better	understanding	of	the	mechanism	that	underlie	gender	inequalities	in	blindness	
and	visual	impairment.	Evaluating	gender	inequalities	according	to	current	age	and	age	
of	onset	could	allow	us	to	understand	whether	gender	inequalities	can	be	related	to	an	
earlier	or	later	incidence	by	sex.	Describing	gender	inequalities	according	to	the	
diagnosed	or	undiagnosed	reason	of	visual	impairment	could	help	understanding	the	
role	of	eye	care	services	and	demands,	and	finally,	reporting	the	causes	of	blindness	and	
visual	impairment	among	people	with	a	diagnosis	may	help	understanding	what	eye	
diseases	could	be	involved	and	concretize	the	actions	to	reduce	the	inequalities,	if	
needed	and	possible.			
Thus,	the	objectives	of	this	study	were	to	analyse	gender	inequalities	in:	1)	the	
prevalence	of	blindness	and	visual	impairment;	2)	the	age	of	onset	of	visual	impairment;	
3)	the	prevalence	of	diagnosed	and	undiagnosed	eye	disease	among	visually	impaired	
people;	and	4)	the	cause	of	blindness	or	visual	impairment	among	people	with	a	
diagnosis.	
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METHODS	
Sample	
Data	were	obtained	from	the	2008	Spanish	Survey	on	“Disability,	Personal	Autonomy	
and	Dependency	Situations”	a	cross-sectional	survey	based	on	a	representative	sample	
of	the	non-institutionalized	population	of	Spain.	The	methods	of	the	survey	are	
described	elsewhere	(12).	The	questionnaire	included	self-reported	information	on	
visual	impairment	and	socio-demographic	data.	The	sample	size,	which	was	the	largest	
produced	in	Spain,	collected	variables	of	visual	impairment	and	blindness	and	was	
selected	using	a	multi-stage	random	sampling	strategy.	The	first-	and	second	stage	units	
were	census	tracts	and	family	households,	respectively.	One	adult	aged	≥15	years	was	
selected	from	each	household	to	complete	the	questionnaire.	A	total	of	213,626	people	
were	interviewed	(103,093	men	and	110,533	women).	Data	were	collected	through	
face-to-face	interviews	at	home	between	November	2007	and	February	2008.	Response	
rate	was	96.1%,	64.6%	of	individuals	were	those	initially	selected,	and	the	rest	were	
replaced	(Ministerio	de	Sanidad	y	Consumo,	2006).	Once	a	household	was	selected,	
failed	initial	attempts	to	contact	the	interviewee	were	followed	up	with	several	
additional	attempts	before	replacing	households	where	all	attempts	failed.		
Measures	
Vision	outcomes	
The	definition	of	visual	impairment	was	based	on	three	questions	focused	on	blindness,	
near	visual	impairment,	and	distance	visual	impairment.	To	determine	the	severity	of	
visual	impairment,	the	following	question	was	asked:	“Are	you	blind	or	only	able	to	
differentiate	between	light	and	darkness?”	Information	on	visual	impairment	was	
elicited	using	the	following	questions:	“Do	you	have	significant	difficulty	reading	
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newspaper	print,	even	when	wearing	glasses	or	contact	lenses?”	and	“Do	you	have	
significant	difficulty	recognizing	someone	across	the	street	(four	meters	distance),	even	
when	wearing	glasses	or	contact	lenses?”	Blind	individuals,	and	those	with	near	or	
distance	visual	impairment	were	classified	as	having	“some	visual	impairment”.	The	
classification	for	blindness	and	visual	impairment	used	in	the	Survey	follows	the	
International	Classification	of	Impairments,	Disabilities	and	Handicaps	(ICIDH).	
Respondents	who	were	blind	or	had	some	visual	impairment	were	asked,	“Have	you	
been	diagnosed	with	any	of	the	following	illnesses?	(cataract,	diabetic	retinopathy,	
glaucoma,	macular	degeneration),	and	those	who	responded	affirmatively	were	
classified	as	having	been	diagnosed	with	each	specific	eye	disease.	Individuals	who	
responded	that	they	had	never	being	diagnosed	with	these	diseases	(representing	90%	
of	blindness	in	Europe)	(13)	nor	with	myopia	magna	or	retinitis	pigmentosa	were	
classified	as	undiagnosed.	
Predictor	variables	
Age	groups	were	constructed	as	follows:	<25	(16	to	24)	years,	25	to	64	years,	65	to	79	
years,	and	≥80	years.	
To	detect	congenital	and	perinatal	conditions,	data	were	collected	on	the	age	of	onset	of	
visual	impairment,	and	were	categorised	as	follows:	≤2	years,	3	to	24	years,	25	to	64	
years,	65	to	79	years,	and	≥80	years.	
A	four-category	co	variable	for	educational	level	was	constructed	depending	on	the	level	
attained	within	the	Spanish	education	system,	as	follows:	1)	illiterate	(unable	to	read	or	
write),	2)	incomplete	primary	education),	3)	complete	primary	education	(or	
equivalent)	and	4)	secondary	or	higher	(including	first	and	second	stage	secondary	
education,	intermediate	and	higher	vocational	studies,	and	university	degree	or	
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equivalent).	When	educational	level	was	introduced	for	adjusting	purposes	in	the	
regression	model,	an	eight-category	co	variable	was	included	in	the	analysis.	
Statistical	analysis	
First,	the	prevalence	of	blindness,	visual	impairment,	diagnosed	and	undiagnosed	eye	
disease,	and	age	of	onset	of	visual	impairment	were	calculated	for	each	gender,	and	also	
separately	for	each	age	group	and	educational	level.	Second,	hierarchical	multiple	
logistic	regression	models	were	fit	to	test	gender	differences,	with	men	as	the	reference	
category.	Model	1	was	adjusted	for	age	(within	the	age	strata),	Model	2	educational	level	
and	Model	3	for	age	and	educational	level.	All	analyses	were	stratified	by	age	group	at	
the	time	of	the	interview	and	educational	level	and	were	carried	out	using	SPSS	v17.0.	
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RESULTS	
Description	of	the	sample		
The	general	description	of	the	sample	is	shown	in	Table	1.	In	both	sexes	the	prevalence	
of	visual	impairment	and	blindness	was	higher	among	individuals	over	65	years,	and	
those	with	less	than	primary	education.	Different	sex	patterns	(p<	0.001)	in	the	
prevalence	of	visual	impairment	and	blindness	were	observed	for	age,	educational	level.		
Gender	inequalities	in	the	prevalence	of	visual	impairment	but	not	blindness	
The	prevalence	of	visual	impairment	was	generally	higher	among	women	than	men	[age	
adjusted	OR=1.4	(95%	CI:1.30-1.46)]	(Table	2);	this	observation	was	not	fully	explained	
by	age	or	educational	level.	The	overall	prevalence	of	blindness	was	0.2	%	and	no	
significant	differences	were	observed	between	men	and	women	[OR=1.2	(95%	CI:	0.95-
1.44)]	(Table	3).		
Gender	inequalities	by	age	group	and	age	of	onset	of	visual	impairment	
Among	individuals	over	24	years,	the	prevalence	of	visual	impairment	was	higher	
among	women	than	men	(Table	2),	and	this	gender	difference	became	more	marked	in	
the	>65	years	age	group;	again,	this	observation	was	not	explained	by	age	within	the	age	
group	or	by	educational	level.	However,	we	observed	no	notable	increase	in	visual	
impairment	in	the	≥80	years	group	compared	to	the	65	to	80	years	group.	No	significant	
gender	differences	were	observed	for	blindness	(Table	3).	Gender	differences	did	not	
vary	markedly	after	adjusting	for	age	and	educational	level	(Table	2).	
Men	were	more	likely	to	become	visually	impaired	[(ORsex=0.7	(95%	CI:	0.56-0.89)]	or	
blind	[(ORsex=0.4	(95%	CI:	0.19-0.76)]	earlier	in	life	(before	age	3	years),	and	women	
later	in	life	[65	to	79	years:	ORsex=1.4	(95%	CI:	1.18-1.60),	and	ORsex=1.8	(95%	CI:	
1.11-2.99),	respectively]	(Table	2	and	3).	Gender	differences	were	partly	explained	by	
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variation	in	age	within	each	age	group.	
Gender	inequalities	in	the	prevalence	of	diagnosed	and	undiagnosed	eye	disease	
Among	individuals	with	some	visual	impairment,	men	(39.8%)	were	more	likely	than	
women	(32.3%)	to	report	that	they	had	not	been	diagnosed	with	eye	disease,	and	this	
difference	was	not	explained	by	age	or	educational	level	[OR=0.8	(95%	CI:	0.71-0.90)]	
(Table	2).	No	gender	differences	were	observed	for	blindness	(Table	3).		
Gender	inequalities	in	the	cause	of	blindness	or	visual	impairment	
Among	visually	impaired	individuals	who	had	been	diagnosed	with	eye	disease,	the	
prevalence	of	cataracts	was	significantly	higher	among	women	[age	and	educational	
level	adjusted	OR=1.3	(95%	CI:	1.08-1.47)],	whereas	glaucoma	was	more	prevalent	
among	men	[(ORsex=0.8	(95%	CI:	0.66-0.95)],	and	these	differences	were	not	explained	
by	age	or	educational	level	(Table	2).	The	prevalence	of	other	diagnoses	was	also	higher	
among	women	after	adjustment	for	age	(ORsex=1.2	(95%	CI:	1.02-1.51)].	We	observed	
no	gender	differences	among	diagnosed	blind	individuals	in	the	prevalence	of	eye	
disease,	except	for	glaucoma	[(ORsex=0.5	(95%	CI:	0.28-0.86)]	(Table	3).		
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DISCUSSION	
This	study	produced	three	main	findings:	1)	the	prevalence	of	visual	impairment	was	
higher	among	women	(after	age	24	years)	and	increased	with	age;	we	observed	no	
gender	differences	in	the	prevalence	of	blindness;	2)	undiagnosed	eye	disease	was	more	
common	among	visually	impaired	men;	3)	among	visually	impaired	people	with	a	
diagnosed	eye	disease,	cataracts	and	“other	diagnoses”	were	more	common	among	
women,	and	glaucoma	was	more	common	among	men.	
As	far	as	we	know	this	is	the	first	study	describing	gender	inequalities	on	the	most	
prevalent	diagnosed	eye	diseases	among	the	visually	impaired	population.	The	results	
are	important	to	help	focus	on	mechanism	and	determinants	for	specific	eye	diseases	
associated	with	the	higher	prevalence	of	visual	impairment	among	women.	Additionally,	
this	is	the	first	time	that	non-diagnosis	eye	diseases	among	the	visually	impaired	and	
the	gender	inequalities	related	are	described,	as	well	as	the	gender	inequalities	related	
to	age	of	onset	the	visual	impairment.		
This	study	was	based	on	a	large,	representative	sample	of	all	regions	of	Spain,	a	high-
income	country,	and	for	the	first	time	we	were	able	to	overcome	some	of	the	previous	
research	limitations	due	to	the	exceptionally	large	data	set.	This	allowed	the	research	to	
stratify	the	analyses	by	sex,	age,	age	of	onset,	diagnosis	status,	and	eye	disease,	while	
controlling	for	age	and	educational	level.	Finally,	at	the	time	of	this	study,	Spain	had	free	
universal	access	to	health	care.	
Gender	inequalities	in	the	prevalence	of	visual	impairment	
Our	results	are	consistent	with	those	of	other	studies	reporting	a	higher	prevalence	of	
visual	impairment	among	women	(2,4).	Since	there	is	no	evidence	of	gender	differences	
in	the	incidence	of	visual	impairment	(14,15)	or	ocular	diseases	(16,17),	and	women	are	
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more	likely	to	seek	early	health	care	assistance	(11,18),	these	results	may	be	partly	due	
to	gender	inequalities	in	diagnosis	or	treatment	effort.	The	Spanish	National	Health	
System	offers	free	and	universal	eye	care	services	for	diagnosis	and	treatment	of	eye	
disease.	However,	of	all	surgeries	and	outpatient	clinics	in	Spain,	cataract	surgery	and	
outpatient	ophthalmology	visits	have	the	longest	waiting	lists	and	the	greatest	number	
of	waiting	days	(19).	Among	women,	less	intense	therapeutic	effort	related	to	
differences	in	waiting	list	prioritization	as	well	as	lower	capacity	to	pay	for	private	
services	could	underlie	the	gender	inequalities	observed	(7,20,21).		
Visual	impairment	was	more	common	in	males	aged	≥24	years,	or	who	had	become	
visually	impaired	or	blind	before	2	years	of	age.	While	childhood	blindness	and	visual	
impairment	is	relatively	rare	compared	to	adult	blindness,	it	remains	a	significant	
problem.	In	Europe,	the	prevalence	of	childhood	blindness	is	between	0.1	and	0.4	per	
1000	children	(22).	Biological	factors	such	as	preterm	birth	are	associated	with	
blindness	and	visual	impairment	among	children	(23),	and	boys	born	before	25	weeks	
gestation	are	more	susceptible	to	visual	impairment	than	girls	(24).	While	gender	
differences	have	not	been	examined	in	detail,	blindness	and	visual	impairment	was	
found	to	be	more	prevalent	among	Swedish	boys	(25)	which	is	consistent	with	our	
findings.	
The	absence	of	gender	differences	in	blindness	may	be	because	the	tendency	among	
women	to	seek	treatment	earlier	and	be	diagnosed	earlier	than	men	is	compensated	by	
the	delay	in	treatment	produced	by	their	lower	therapeutic	effort	(e.g.	women	wait	
almost	twice	as	long	as	men	to	be	operated,	2.9	and	1.73	months,	respectively)(26).	This	
effect,	combined	with	long	waiting	lists	for	cataract	surgery	in	Spain	and	the	use	of	a	
relatively	low	mean	Visual	Acuity	(VA)	at	which	cataract	surgery	is	indicated	by	
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ophthalmologists	in	Spain	(mean	VA=0,07	in	Spain	vs	mean	VA	=	0.17	in	Denmark)	(27),	
could	explain	why	gender	inequalities	tend	to	disappear	as	visual	impairment	
deteriorates	and	becomes	blindness.		
Gender	differences	in	the	prevalence	of	non-diagnosed	visual	impairment	
Non-diagnosis	of	eye	diseases	among	the	visually	impaired	does	not	explain	the	gender	
differences	observed	in	visual	impairment,	as	it	is	more	frequent	among	men	(39.8%	of	
men	and	32.2%	of	women).	The	role	of	traditional	masculinity	and	the	consequences	in	
relation	to	the	use	of	health	care	services,	could	again	be	involved	in	the	higher	
prevalence	of	non-diagnosis	of	eye	diseases	observed.	The	traditional	social	model	of	
hegemonic	masculinity	conditions	men	to	control	themselves,	be	active,	strong,	endure	
pain,	and	not	seek	help	(28,29).	This	social	model	is	associated	with	risky	behaviors	that	
are	also	linked	to	their	lower	life	expectancy	compared	to	women,	including:	difficulty	in	
admitting	that	they	have	symptoms	of	body	alarm,;	postponing	discomfort	as	it	is	
experienced	as	an	uncontrollable	threat	of	his	body,	delaying	attendance	at	health	
services	because	it	is	perceived	as	a	failure	of	self-sufficiency;	and	poor	adherence	to	
treatment	(9,10,30).	For	example	it	has	been	reported	that	41.7%	of	men	in	the	US	who	
reported	visual	impairment	but	did	not	seek	care,	indicating	“no	need”	as	the	main	
reason,	compared	to	28.7%	of	women.(18)			
Gender	differences	in	the	diagnosed	causes	of	visual	impairment	
Cataract	accounted	for	most	of	the	gender	inequalities	observed	and	it	was	more	
common	among	visually	impaired	women	(71.6%	vs	63.6%).	This	is	a	highly	treatable	
ambulatory	condition	that	is	provided	free	for	Spanish	citizens	and	as	a	consequence,	no	
major	clinical	or	economic	barriers	would	be	expected.	However,	of	all	surgeries	and	
outpatient	clinics	in	Spain,	cataract	surgery	has	the	largest	waiting	lists	and	the	greatest	
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number	of	waiting	days.(31)	The	lack	of	objective	criteria	in	the	prioritization	of	
cataract	surgery	waiting	lists	in	Spain	(32)	has	being	pointed	out		as	a	determinant	
factor	for	inequalities	and	gender	discrimination	as	women	wait	almost	twice	as	long	as	
men	to	be	operated	on	in	the	Spanish	public	system	(2.9	and	1.73	months,	respectively).	
(26)	In	addition,	patients	may	experience	a	“post-referral	waiting”	that	is,	between	
referral	and	inclusion	in	the	waiting	list.(33)	The	consequence	of	gender	discrimination	
as	an	easier	acceptance	and	higher	priority	among	men	for	the	cataract	surgery	waiting	
list	(34)	could	explain	why	while	women	compose	68,9%	of	the	diagnosed	cataract,	they	
only	represented	57,2%	of	the	cataract	surgeries	reported	in	the	public	system	
according	to	Spanish	data.(35)	However,	this	is	speculative	and	deserves	further	
research.		
The	role	of	traditional	masculinity	and	the	consequences	in	relation	to	the	use	of	health	
care	services,	as	men’s	tendency	to	delay	health	care	attendance	and	non-compliance	for	
regular	check-ups	and	treatments	(9,10),	may	cause	them	to	develop	advanced	disease	
that	can	no	longer	be	treated	and	could	explain	the	higher	prevalence	of	glaucoma	as	the	
cause	of	visual	impairment	and	blindness	among	men.	According	to	multiple	studies,	
approximately	half	of	people	with	glaucoma	are	unaware	of	it,	which	is	particularly	
worrying	because	glaucoma	leads	to	irreversible	loss	of	vision.(36)	For	this	reason,	
going	to	regular	check-ups	is	crucial	in	detecting	glaucoma	symptoms	and	lowering	
intraocular	pressure	that	prevents	loss	of	vision.		
In	conclusion,	we	observed	strong	gender	inequalities	in	visual	impairment	in	Spain,	
with	a	higher	prevalence	of	visual	impairment	and	related	cataracts	among	women,	and	
undiagnosed	eye	disease	and	related	glaucoma	among	men.	Women	discrimination,	
especially	when	prioritizing	cataract	surgery	waiting	lists,	and	hegemonic	masculinity	
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cunductual	behaviors	related	to	men’s	less	frequent	and	effective	use	of	health	care	
services	could	be	associated	with	the	gender	inequalities	observed.	These	results	
highlight	the	need	to	implement	policies	to	reduce	gender	inequalities	in	the	prevalence	
of	visual	impairment	related	to	health	care	access.	Sensitization	actions	to	prevent	
discrimination	of	women	when	prescribing	treatment	or	prioritizing	for	waiting	list	
among	professionals	are	recommended.	Awareness	campaigns	and	programs	focused	on	
detecting	visual	impairment	and	related	eye	disease	among	men	are	also	suggested.	
More	research	is	needed	to	clarify	the	potential	economic	reasons	for	the	gender	
inequalities	observed.		
 
Limitations	
While	clinical	examinations	were	not	conducted	in	this	study,	previous	studies	support	
the	validity	of	self-reported	data	on	visual	impairment	when	compared	with	visual	
acuity	measurements	(37,38).	Nonetheless,	a	higher	sensitivity	between	low	visual	
acuity	and	self	reported	visual	impairment	is	found	among	women	(39),	which	could	
again	be	associated	with	traditional	masculinity,	in	that	men	are	more	likely	to	deny	
their	impairment	when	interviewed.	This	could	lead	us	to	underestimate	the	prevalence	
of	visual	impairment	among	men.	
The	variable	for	undiagnosed	eye	disease	included	individuals	who	were	not	diagnosed	
with	cataract,	diabetic	retinopathy,	glaucoma	and	macular	degeneration	(representing	
90%	of	blindness	in	Europe)	(1),	as	well	as	myopia	magna	and	retinitis	pigmentosa.	
However,	gender	differences	in	other,	uncommon,	eye	diseases	could	partly	explain	the	
gender	inequalities	observed,	although	we	found	no	evidence	of	this.	
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Key-points	
• Strong	gender	inequalities	in	visual	impairment	in	Spain,	with	a	higher	
prevalence	of	visual	impairment	and	related	cataracts	among	women,	and	
undiagnosed	eye	disease	and	related	glaucoma	among	men	are	observed.		
• As	far	as	we	know	this	is	the	first	study	describing	gender	inequalities	on	the	
non-diagnosed	and	diagnosed	eye	diseases	among	the	visually	impaired	
population.		
• Sensitization	actions	to	prevent	discrimination	of	women	when	prescribing	
treatment	or	prioritizing	for	waiting	list	among	professionals	are	recommended.	
• Awareness	campaigns	and	programs	focused	on	detecting	visual	impairment	and	
related	eye	disease	among	men	are	also	suggested.		
• More	research	is	needed	to	help	focusing	on	mechanisms	and	determinants	for	
the	higher	prevalence	of	visual	impairment	and	cataract	among	women.		
	
Page 16 of 23
http://mc.manuscriptcentral.com/ejph
Manuscripts submitted to European Journal of Public Health
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
For Review Only
17 
 
REFERENCES	
1.		 World	Health	Organization	(WHO).	WHA62.1.	Prevention	of	Avoidable	blindness	and	
visual	impairment.	p.	1–30.		
2.		 Stevens	GA,	White	RA,	Flaxman	SR,	Price	H,	Jonas	JB,	Keeffe	J,	et	al.	Global	prevalence	of	
vision	impairment	and	blindness:	magnitude	and	temporal	trends,	1990-2010.	
Ophthalmology.	2013;120(12):2377–84.		
3.		 Gordois	A,	Cutler	H,	Pezzullo	L,	Gordon	K,	Cruess	A,	Winyard	S,	et	al.	An	estimation	of	the	
worldwide	economic	and	health	burden	of	visual	impairment.	Vol.	7,	Global	Public	Health.	
2012.	p.	465–81.		
4.		 Abou-Gareeb	I,	Lewallen	S,	Bassett	K,	Courtright	P.	Gender	and	blindness:	a	meta-analysis	
of	population-based	prevalence	surveys.	Ophthalmic	Epidemiol.	2001;8:39–56.		
5.		 The	Eye	Diseases	Prevalence	Research	Group.	Causes	and	Prevalence	of	Visual	
Impairment	Among	Adults	in	the	United	States.	Arch	Ophthalmol.	2004;122:477–85.		
6.		 Lewallen	S,	Mousa	A,	Bassett	K,	Courtright	P.	Cataract	surgical	coverage	remains	lower	in	
women.	Br	J	Ophthalmol.	2009	Mar;93(3):295–8.		
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Table 1. General description of the sample (in percentages). Survey on Disability, Personal Autonomy and 
Dependency. 
            
Variables Total Population   Blindness   Some Visual Impairment 
 Males (%) Females (%)   Males (%) Females (%)   Males (%) Females (%)  
  N=103,093 N=110,533 p-valuea  N = 160 N = 200 p-valuea  N = 2025 N = 3535 p-valuea 
Age group (years)  < 0.001    0.004    < 0.001 
16-24 12.8 11.5   3.8 1.0   1.6 0.8  
25-64 67.9 65.2   26.9 18.0   32.8 23.8  
65-79 14.9 16.4   34.4 28.5   36.5 36.6  
≥80 4.4 6.8   35.0 52.5   29.0 38.8  
Educational level  < 0.001    0.003    < 0.001 
Illiterate 1.8 3.7   12.0 24.2   8.1 16.7  
Less than Primary 13.5 15.9   34.6 35.4   36.8 39.4  
Complete Primary 27.9 26.6   28.3 27.3   31.2 28.3  
Secondary or higher 56.9 53.8   25.2 13.1   23.9 15.5  
            
a
 Chi-squared test/Fisher's exact test comparing distribution among men compared to women  
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Table 2. Crude Prevalence, OR, Adjusted OR and 95% Confidence Interval (CIs) for gender inequalities in the prevalence of some visual impairment, and diagnosed and 
undiagnosed eye diseases. Survey on Disability, Personal Autonomy and Dependency. 
 SOME VISUAL IMPAIRMENT 
     ORc (IC 95%)  ORa (IC 95%) Model 1  ORa (IC 95%) Model 2  ORa (IC 95%) Model 3 
 Prevalence %     Adjusted for Age  Adjusted for educational level  
Adjusted for age and educational 
level 
 Men Women P-value
a 
 OR 95% CI P-value
a 
 aOR 95% CI P-value
a 
 aOR 95% CI P-value
a 
 aOR 95% CI P-value
a 
Total 2.0 3.2   1.6 (1.56, 1.74) < 0.001  1.4 (1.30, 1.46) < 0.001  1.5 (1.46, 1.63) < 0.001  1.3 (1.27, 1.42) < 0.001 
Age group                    
16-24 0.3 0.2   0.9 (0.51, 1.41) 0.526  0.9 (0.51, 1.42) 0.543  1.0 (0.59, 1.64) 0.98  1.0 (0.61, 1.71) 0.93 
25-64 1.0 1.2   1.2 (1.11, 1.36) < 0.001  1.2 (1.10, 1.35) < 0.001  1.2 (1.12, 1.37) < 0.001  1.2 (1.08, 1.33) 0.001 
65-79 4.8 7.1   1.5 (1.39. 1.67) < 0.001  1.5 (1.36, 1.64) < 0.001  1.4 (1.32, 1.59) < 0.001  1.4 (1.31, 1.58) < 0.001 
≥80 13.0 18.2   1.5 (1.35, 1.66) < 0.001  1.4 (1.25, 1.54) < 0.001  1.5 (1.34, 1.65) < 0.001  1.4 (1.24, 1.53) < 0.001 
Age of onset
b
   < 0.001                 
<3 12.6 8.5   0.7 (0.56, 0.89) 0.003  1.0 (0.77, 1.27) 0.941  0.7 (0.57, 0.89) 0.003  1.0 (0.77, 1.28) 0.962 
3-24 11.1 9.1   0.9 (0.69, 1.11) 0.264  1.2 (0.90, 1.48) 0.249  0.9 (0.70, 1.11) 0.277  1.2 (0.91, 1.48) 0.243 
25-64 38.4 34.6   1.0 (0.84, 1.10) 0.55  1.0 (0.90, 1.19) 0.619  1.0 (0.84, 1.10) 0.556  1.0 (0.89, 1.17) 0.74 
65-79 25.9 31.4   1.4 (1.18, 1.60) < 0.001  1.2 (1.00, 1.36) 0.058  1.3 (1.10, 1.49) 0.002  1.1 (0.98, 1.33) 0.101 
≥80 11.9 16.4   1.5 (1.25, 1.89) < 0.001  1.0 (0.78, 1.28) 0.987  1.5 (1.24, 1.88) < 0.001  1.0 (0.78, 1.28) 0.982 
Diagnosis status
b
   < 0.001                 
Diagnosed eye disease 60.2 67.8   1.4 (1.24, 1.56) < 0.001  1.3 (1.11, 1.40) < 0.001  1.4 (1.24, 1.56) < 0.001  1.3 (1.12, 1.41) < 0.001 
Undiagnosed eye disease 39.8 32.3   0.7 (0.64, 0.81) < 0.001  0.8 (0.71, 0.90) < 0.001  0.7 (0.64, 0.81) < 0.001  0.8 (0.71, 0.90) < 0.001 
Diagnosed eye disease
c,d
   < 0.001                 
Cataract 63.6 71.6   1.4 (1.25, 1.67) < 0.001  1.3 (1.08, 1.47) 0.003  1.4 (1.24, 1.66) < 0.001  1.3 (1.08, 1.47) 0.003 
Glaucoma 19.4 15.7   0.8 (0.65, 0.93) 0.006  0.8 (0.66, 0.95) 0.011  0.8 (0.65, 0.93) 0.006  0.8 (0.66, 0.95) 0.011 
Macular degeneration 8.9 10.6   1.2 (0.96, 1.54) 0.108  1.1 (0.89, 1.43) 0.317  1.2 (0.96, 1.54) 0.105  1.1 (0.89, 1.44) 0.304 
Diabetic retinopathy 13.2 13.6   1.0 (0.85, 1.27) 0.737  1.1 (0.87, 1.32) 0.500  1.0 (0.83, 1.24) 0.909  1.0 (0.85, 1.28) 0.685 
Other diagnosis 16.2 16.2   1.0 (0.83, 1.21) 1.000  1.2 (1.02, 1.51) 0.035  1.0 (0.83, 1.21) 0.976  1.2 (1.01, 1.51) 0.036 
 
a
 Chi-squared test/Fisher's exact test comparing distribution among men and women 
b
 Visually impaired or blind individuals only                 
c 
Among diagnosed individuals with some visual impairment              
d 
Note that individuals can have more than one diagnosed eye disease             
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Table 3. Crude Prevalence, OR and 95% Confidence Interval (CIs) for gender inequalities in 
the prevalence of blindness, and diagnosed and undiagnosed eye diseases. Survey on 
Disability, Personal Autonomy and Dependency. 
 BLINDNESS 
        
 Prevalence %   ORc (IC 95%) 
 Men Women p-valuea  OR 95% CI P-valuea 
Total 0.2 0.2   1.2 (0.95, 1.44) 0.148 
Age group        
16-24 0.1 0.0   0.3 (0.07, 1.71) 0.193 
25-64 0.1 0.1   0.8 (0.52, 1.27) 0.357 
65-79 0.4 0.3   0.9 (0.61, 1.27) 0.490 
≥80 1.2 1.4   1.1 (0.82, 1.57) 0.451 
Age of onset
b
   0.001     
<3 16.5 6.6   0.4 (0.19, 0.76) 0.007 
3-24 8.6 11.2   1.4 (0.68, 2.87) 0.362 
25-64 38.8 29.1   0.7 (0.44, 1.06) 0.092 
65-79 20.4 31.1   1.8 (1.11, 2.99) 0.017 
≥80 15.8 21.9   1.6 (0.90, 2.69) 0.117 
Diagnostic status
b
   0.822     
Diagnosed eye disease 66.3 67.5   1.1 (0.68, 1.65) 0.802 
Undiagnosed eye disease 33.8 32.5   1.0 (0.61, 1.47) 0.802 
Diagnosed eye diseases
c,d
   < 0.001     
Cataract 50.0 58.5   1.4 (0.85, 2.35) 0.188 
Glaucoma 37.7 23.0   0.5 (0.28, 0.86) 0.013 
Macular degeneration 9.4 17.8   2.1 (0.95, 4.56) 0.069 
Diabetic retinopathy 18.9 20.7   1.1 (0.59, 2.13) 0.718 
Other diagnosis 28.3 25.9   0.9 (0.50, 1.57) 0.680 
a
 Chi-squared test/Fisher's exact test comparing distribution among men and women. 
b
 Blind individuals only        
c  
Among blind individuals with diagnosed eye disease     
d 
Note that individuals can have more than one diagnosed eye disease  
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